Back
Corporate News
Venmax Drugs to review quarterly results and warrants at August 7 board meeting
01-Aug-2026, 05:09
Venmax Drugs and Pharmaceuticals Limited will hold a board meeting on Friday, August 7, 2026, at 4:00 P.M. to consider and approve the unaudited financial results for the quarter ended June 30, 2026, and the forfeiture of partly paid-up share warrants. The trading window for the company’s securities will remain closed for designated persons from July 1, 2026, until August 9, 2026.
Venmax Drugs and Pharmaceuticals Limited will hold a board meeting on Friday, August 7, 2026, at 4:00 P.M. to consider and approve the unaudited financial results for the quarter ended June 30, 2026, and the forfeiture of partly paid-up share warrants. The trading window for the company’s securities will remain closed for designated persons from July 1, 2026, until August 9, 2026.